Report cover image

North America Circulating Tumor Cell Market Size, Share & Trends Analysis Report By Product, By End User, Based on Specimen, By Technology, By Application (Research, Clinical, and Drug/Therapy Development), By Country and Growth Forecast, 2024 - 2031

Publisher Knowledge Based Value (KBV) Research
Published Jan 10, 2025
Length 105 Pages
SKU # KBV19494114

Description

North America Circulating Tumor Cell Market Size, Share & Trends Analysis Report By Product, By End User, Based on Specimen, By Technology, By Application (Research, Clinical, and Drug/Therapy Development), By Country and Growth Forecast, 2024 - 2031


The North America Circulating Tumor Cell Market would witness market growth of 12.5% CAGR during the forecast period (2024-2031).

The US market dominated the North America Circulating Tumor Cell Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $6,117.7 million by 2031. The Canada market is experiencing a CAGR of 14.9% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 14% during (2024 - 2031).

Another key application of CTCs is in assessing the efficacy of cancer treatments. Traditional methods of evaluating treatment response, such as imaging and biopsies, can be invasive and may not provide immediate feedback.

Additionally, CTCs, on the other hand, allow for real-time monitoring of tumor behavior, offering insights into whether a treatment is working or if resistance is developing. This facilitates a more agile approach to oncology, enabling adjustments to the treatment plan before the cancer worsens.

The highest prevalence was observed in cancers such as breast, prostate, thyroid, colon, and cervical cancer. With this rising cancer burden, there is a growing need for more effective diagnostic and monitoring solutions. CTCs, a non-invasive method for detecting cancer cells circulating in the bloodstream, can revolutionize cancer diagnosis and treatment monitoring in Mexico. As the healthcare system in Mexico continues to improve and expand, the demand for advanced diagnostic tools like CTCs will grow, leading to increased market opportunities.

Based on Product, the market is segmented into Kits & Reagents, Devices, and Blood Collection Tubes. Based on End User, the market is segmented into Research and Academic Institutes, Hospital & Clinics, and Diagnostic Centers. Based on Specimen, the market is segmented into Blood, Bone Marrow, and Other Specimen. Based on Technology, the market is segmented into CTC Detection & Enrichment Methods, CTC Analysis, and CTC Direct Detection. Based on Application, the market is segmented into Research, Clinical, and Drug/Therapy Development. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled
  • Qiagen N.V
  • Greiner Bio-One International GmbH
  • Sysmex Corporation
  • Miltenyi Biotech B.V & Co kg
  • Bio-Techne Corporation
  • Ikonisys, Inc.
  • Menarini Silicon Biosystems SpA
  • LungLife AI Inc.
  • Aviva Systems Biology Corporation
  • ScreenCell
North America Circulating Tumor Cell Market Report Segmentation

By Product
  • Kits & Reagents
  • Devices
  • Blood Collection Tubes
By End User
  • Research and Academic Institutes
  • Hospital & Clinics
  • Diagnostic Centers
By Specimen
  • Blood
  • Bone Marrow
  • Other Specimen
By Technology
  • CTC Detection & Enrichment Methods
  • CTC Analysis
  • CTC Direct Detection
By Application
  • Research, Clinical
  • Drug/Therapy Development
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America

Table of Contents

105 Pages
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Circulating Tumor Cell Market, by Product
1.4.2 North America Circulating Tumor Cell Market, by End User
1.4.3 North America Circulating Tumor Cell Market, by Specimen
1.4.4 North America Circulating Tumor Cell Market, by Technology
1.4.5 North America Circulating Tumor Cell Market, by Application
1.4.6 North America Circulating Tumor Cell Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. North America Circulating Tumor Cell Market by Product
4.1 North America Kits & Reagents Market by Country
4.2 North America Devices Market by Country
4.3 North America Blood Collection Tubes Market by Country
Chapter 5. North America Circulating Tumor Cell Market by End User
5.1 North America Research and Academic Institutes Market by Country
5.2 North America Hospital & Clinics Market by Country
5.3 North America Diagnostic Centers Market by Country
Chapter 6. North America Circulating Tumor Cell Market by Specimen
6.1 North America Blood Market by Country
6.2 North America Bone Marrow Market by Country
6.3 North America Other Specimen Market by Country
Chapter 7. North America Circulating Tumor Cell Market by Technology
7.1 North America CTC Detection & Enrichment Methods Market by Country
7.2 North America CTC Analysis Market by Country
7.3 North America CTC Direct Detection Market by Country
Chapter 8. North America Circulating Tumor Cell Market by Application
8.1 North America Research, Clinical Market by Country
8.2 North America Drug/Therapy Development Market by Country
Chapter 9. North America Circulating Tumor Cell Market by Country
9.1 US Circulating Tumor Cell Market
9.1.1 US Circulating Tumor Cell Market by Product
9.1.2 US Circulating Tumor Cell Market by End User
9.1.3 US Circulating Tumor Cell Market by Specimen
9.1.4 US Circulating Tumor Cell Market by Technology
9.1.5 US Circulating Tumor Cell Market by Application
9.2 Canada Circulating Tumor Cell Market
9.2.1 Canada Circulating Tumor Cell Market by Product
9.2.2 Canada Circulating Tumor Cell Market by End User
9.2.3 Canada Circulating Tumor Cell Market by Specimen
9.2.4 Canada Circulating Tumor Cell Market by Technology
9.2.5 Canada Circulating Tumor Cell Market by Application
9.3 Mexico Circulating Tumor Cell Market
9.3.1 Mexico Circulating Tumor Cell Market by Product
9.3.2 Mexico Circulating Tumor Cell Market by End User
9.3.3 Mexico Circulating Tumor Cell Market by Specimen
9.3.4 Mexico Circulating Tumor Cell Market by Technology
9.3.5 Mexico Circulating Tumor Cell Market by Application
9.4 Rest of North America Circulating Tumor Cell Market
9.4.1 Rest of North America Circulating Tumor Cell Market by Product
9.4.2 Rest of North America Circulating Tumor Cell Market by End User
9.4.3 Rest of North America Circulating Tumor Cell Market by Specimen
9.4.4 Rest of North America Circulating Tumor Cell Market by Technology
9.4.5 Rest of North America Circulating Tumor Cell Market by Application
Chapter 10. Company Profiles
10.1 Qiagen N.V.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Regional Analysis
10.1.4 Research & Development Expenses
10.1.5 Recent strategies and developments:
10.1.5.1 Partnerships, Collaborations, and Agreements:
10.1.6 SWOT Analysis
10.2 Greiner Bio-One International GmbH
10.2.1 Company Overview
10.2.2 SWOT Analysis
10.3 Sysmex Corporation
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Research & Development Expenses
10.3.4 SWOT Analysis
10.4 Miltenyi Biotech B.V. & Co. KG
10.4.1 Company Overview
10.4.2 SWOT Analysis
10.5 Bio-Techne Corporation
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expenses
10.5.5 SWOT Analysis
10.6 Ikonisys, Inc.
10.6.1 Company Overview
10.7 Menarini Silicon Biosystems SpA
10.7.1 Company Overview
10.8 LungLife AI Inc.
10.8.1 Company Overview
10.8.2 Financial Analysis
10.9 Aviva Systems Biology Corporation
10.9.1 Company Overview
10.10. ScreenCell
10.10.1 Company Overview

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us